Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Adamis Pharmaceuticals Corp Company Profile (NASDAQ:ADMP)

Consensus Ratings for Adamis Pharmaceuticals Corp (NASDAQ:ADMP) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $12.50 (192.74% upside)

Analysts' Ratings History for Adamis Pharmaceuticals Corp (NASDAQ:ADMP)
Show:
DateFirmActionRatingPrice TargetActions
5/29/2015MizuhoInitiated CoverageBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2014CRT CapitalReiterated RatingPositive$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/28/2014CRT CapitalInitiated CoverageBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/30/2013 forward)